In comparison, neuron-specific MANF expression in vivo improved the outcome in the 6-OHDA toxin model of Parkinson’s disease by reducing the levels of p-eIF2a, ATF4, CHOP, XBP1s, GRP78, and ATF6α (Hao et al., 2017). Here, MANF is linked to Parkinson disease.